loadpatents
name:-0.050179004669189
name:-0.023225069046021
name:-0.004453182220459
Silence; Karen Patent Filings

Silence; Karen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Silence; Karen.The latest application filed is for "therapeutic musk antibodies".

Company Profile
2.24.49
  • Silence; Karen - Overijse BE
  • SILENCE; Karen - Ghent BE
  • Silence; Karen - Breda NL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antibodies to CD70
Grant 11,434,298 - Silence , et al. September 6, 2
2022-09-06
Therapeutic Musk Antibodies
App 20220259304 - BURDEN; Steven J. ;   et al.
2022-08-18
Antibodies to CD70
Grant 11,072,665 - Silence , et al. July 27, 2
2021-07-27
Polypeptides and polypeptide constructs comprising single domain antibodies directed against von willebrand factor
Grant 11,034,755 - Silence June 15, 2
2021-06-15
Antibodies To Cd70
App 20190270823 - Silence; Karen ;   et al.
2019-09-05
Anti-CD70 combination therapy
Grant 10,391,168 - Riether , et al. A
2019-08-27
Polypeptides And Polypeptide Constructs Comprising Single Domain Antibodies Directed Against Von Willebrand Factor
App 20190112363 - Silence; Karen
2019-04-18
Polypeptides and polypeptide constructs comprising single domain antibodies directed against von Willebrand factor
Grant 10,112,989 - Silence October 30, 2
2018-10-30
Chimeric human-llama antigens and methods of use
Grant 9,926,364 - De Haard , et al. March 27, 2
2018-03-27
Antibodies To Cd70
App 20170369581 - SILENCE; Karen ;   et al.
2017-12-28
Antibodies to CD70
Grant 9,765,148 - Silence , et al. September 19, 2
2017-09-19
Antibodies to CD70
Grant 9,765,149 - Silence , et al. September 19, 2
2017-09-19
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
Grant 9,725,522 - Bouche , et al. August 8, 2
2017-08-08
Stabilized Single Domain Antibodies
App 20170107302 - SILENCE; KAREN ;   et al.
2017-04-20
Single Domain Antibodies Directed Against Tumor Necrosis Factor-alpha And Uses Therefor
App 20170096481 - SILENCE; KAREN ;   et al.
2017-04-06
Pulmonary Administration Of Immunoglobulin Single Variable Domains And Constructs Thereof
App 20160280799 - BOUCHE; MARIE-PAULE LUCIENNE ARMANDA ;   et al.
2016-09-29
Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor
Grant 9,371,381 - Silence , et al. June 21, 2
2016-06-21
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
Grant 9,320,792 - Bouche , et al. April 26, 2
2016-04-26
Polypeptide constructs including VHH directed against EGFR for intracellular delivery
Grant 9,243,065 - Silence , et al. January 26, 2
2016-01-26
Polypeptides And Polypeptide Constructs Comprising Single Domain Antibodies Directed Against Von Willebrand Factor
App 20150299301 - Silence; Karen
2015-10-22
Antibodies To Cd70
App 20150266963 - SILENCE; Karen ;   et al.
2015-09-24
Polypeptides and polypeptide constructs comprising single domain antibodies directed against von Willebrand factor
Grant 9,028,816 - Silence May 12, 2
2015-05-12
Single Domain Antibodies Directed Against Tumor Necrosis Factor-alpha And Uses Therefor
App 20150110782 - Silence; Karen ;   et al.
2015-04-23
Stabilized Single Domain Antibodies
App 20150064182 - Silence; Karen ;   et al.
2015-03-05
Chimeric Human-llama Antigens And Methods Of Use
App 20140286976 - De Haard; Johannes Joseph Wilhelmus ;   et al.
2014-09-25
Antibodies to CD70
Grant 8,834,882 - Silence , et al. September 16, 2
2014-09-16
Antibodies To Cd70
App 20140235843 - SILENCE; Karen ;   et al.
2014-08-21
Antibodies To Cd70
App 20140147450 - SILENCE; Karen ;   et al.
2014-05-29
Antibodies To Cd70
App 20140141016 - Silence; Karen ;   et al.
2014-05-22
Von Willebrand Factor Specific Binders And Methods Of Use Therefor
App 20140044710 - Holz; Josefin-Beate ;   et al.
2014-02-13
Pulmonary Administration Of Immunoglobulin Single Variable Domains And Constructs Thereof
App 20130136744 - Bouche; Marie-Paule Lucienne Armanda ;   et al.
2013-05-30
Single Domain VHH Antibodies Against Von Willebrand Factor
App 20130136736 - Silence; Karen
2013-05-30
Single domain VHH antibodies against Von Willebrand Factor
Grant 8,372,398 - Silence February 12, 2
2013-02-12
Stabilized Single Domain Antibodies
App 20120251540 - Silence; Karen ;   et al.
2012-10-04
Single Domain Antibodies Directed Against Tumor Necrosis Factor-alpha And Uses Therefor
App 20120202977 - Silence; Karen ;   et al.
2012-08-09
Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
Grant 8,097,251 - Muyldermans , et al. January 17, 2
2012-01-17
Single Domain Antibodies Directed Against Epidermal Growth Factor Receptor And Uses Therefor
App 20110184151 - Laeremans; Toon ;   et al.
2011-07-28
Method Of Administering Therapeutic Polypeptides, And Polypeptides Therefor
App 20110184145 - SILENCE; KAREN ;   et al.
2011-07-28
Single Domain Antibodies Directed Against Tumor Necrosis Factor-alpha And Uses Therefor
App 20110184150 - Silence; Karen ;   et al.
2011-07-28
Stabilized Single Domain Antibodies
App 20110178277 - Silence; Karen ;   et al.
2011-07-21
Von Willebrand Factor Specific Binders And Methods Of Use Therefor
App 20110158996 - Holz; Josefin-Beate ;   et al.
2011-06-30
Single Domain Antibodies Directed Against Epidermal Growth Factor Receptor And Uses Therefor
App 20110123529 - Laeremans; Toon ;   et al.
2011-05-26
Methods and assays for distinguishing between different forms of diseases and disorders characterized by thrombocytopenia and/or by spontaneous interaction between Von Willebrand Factor (vWF) and platelets
Grant 7,939,277 - de Groot , et al. May 10, 2
2011-05-10
Single Domain Antibodies Directed Against Tumor Necrosis Factor-alpha And Uses Therefor
App 20110027281 - Silence; Karen ;   et al.
2011-02-03
Single Domain Vhh Antibodies Against Von Willebrand Factor
App 20100330084 - Silence; Karen
2010-12-30
Single domain VHH antibodies against von Willebrand factor
Grant 7,807,162 - Silence October 5, 2
2010-10-05
Polypeptide Constructs For Sublingual Administration
App 20100040613 - Silence; Karen ;   et al.
2010-02-18
Polypeptide Constructs For Intracellular Delivery
App 20100021459 - Silence; Karen ;   et al.
2010-01-28
Nanobodies for the treatment of aggregation-mediated disorders
App 20100022452 - Silence; Karen
2010-01-28
Polypeptide Constructs For Topical Administration
App 20100003249 - Silence; Karen ;   et al.
2010-01-07
Single Domain Antibodies Directed Against Epidermal Growth Factor Receptor And Uses Therefor
App 20100003253 - Laeremans; Toon ;   et al.
2010-01-07
Polypeptide Constructs For Rectal And/or Vaginal Administration
App 20100003248 - Silence; Karen ;   et al.
2010-01-07
Polypeptide Constructs For Nasal Administration
App 20090324512 - Silence; Karen ;   et al.
2009-12-31
Stabilized single domain antibodies
App 20090238829 - Silence; Karen ;   et al.
2009-09-24
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
App 20090022721 - Silence; Karen ;   et al.
2009-01-22
Methods And Assays For Distinguishing Between Different Forms Of Diseases And Disorders Characterized By Thrombocytopenia And/Or By Spontaneous Interaction Between Von Willebrand Factor (Vwf) And Platelets
App 20080096223 - De Groot; Philip G. ;   et al.
2008-04-24
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
App 20070237769 - Silence; Karen ;   et al.
2007-10-11
Stabilized single domain antibodies
App 20070178082 - Silence; Karen ;   et al.
2007-08-02
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
App 20070077249 - Silence; Karen ;   et al.
2007-04-05
Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation
App 20060149041 - Silence; Karen
2006-07-06
Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders
App 20060115470 - Silence; Karen ;   et al.
2006-06-01
Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
App 20060034845 - Silence; Karen ;   et al.
2006-02-16
Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
App 20030165877 - Muyldermans, Serge ;   et al.
2003-09-04
Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
App 20030148508 - Muyldermans, Serge ;   et al.
2003-08-07
Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
Grant 6,479,280 - Muyldermans , et al. November 12, 2
2002-11-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed